Cargando…
Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication
The history of the human immunodeficiency virus (HIV)/AIDS therapy, which spans over 30 years, is one of the most dramatic stories of science and medicine leading to the treatment of a disease. Since the advent of the first AIDS drug, AZT or zidovudine, a number of agents acting on different drug ta...
Autores principales: | Maeda, Kenji, Das, Debananda, Kobayakawa, Takuya, Tamamura, Hirokazu, Takeuchi, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132033/ https://www.ncbi.nlm.nih.gov/pubmed/31424371 http://dx.doi.org/10.2174/1568026619666190712204603 |
Ejemplares similares
-
A Therapeutic Strategy to Combat HIV-1 Latently Infected Cells With a Combination of Latency-Reversing Agents Containing DAG-Lactone PKC Activators
por: Matsuda, Kouki, et al.
Publicado: (2021) -
Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C–induced HIV latency reversal
por: Matsuda, Kouki, et al.
Publicado: (2019) -
Small-Molecule Anti-HIV-1 Agents Based on HIV-1 Capsid Proteins
por: Kobayakawa, Takuya, et al.
Publicado: (2021) -
Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins
por: Kobayakawa, Takuya, et al.
Publicado: (2023) -
Cellular and Molecular Regulation of Spiral Artery Remodelling: Lessons from the Cardiovascular Field
por: Whitley, G.St.J., et al.
Publicado: (2010)